Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Treatment‐related experiences and preferences of patients with lung cancer: a qualitative analysis
Beteiligte:
Aumann, Ines;
Kreis, Kristine;
Damm, Kathrin;
Golpon, Heiko;
Welte, Tobias;
Graf von der Schulenburg, J. Matthias
Erschienen:
Wiley, 2016
Erschienen in:
Health Expectations, 19 (2016) 6, Seite 1226-1236
Sprache:
Englisch
DOI:
10.1111/hex.12417
ISSN:
1369-7625;
1369-6513
Entstehung:
Anmerkungen:
Beschreibung:
AbstractBackgroundLung cancer is one of the most common types of cancer worldwide, and it causes significant challenges for patients due to the poor survival rate and treatment‐related side‐effects. Because of lung cancer's great burden, identification and use of the patients' preferences can help to improve patients' quality of life.ObjectiveInterviews with patients who have lung cancer were used to ascertain a range of experiences and to make recommendations regarding the improvement of treatment based on these patients' preferences. Because chemotherapy is the common treatment option for lung cancer, we focused on this treatment. The interviews were audio‐taped, verbally transcribed and evaluated via content analysis.Setting and ParticipantsA total of 18 participants (11 men and 7 women) with small or non‐small‐cell lung cancer who were receiving chemotherapy in one clinic were interviewed between June and July 2013.ResultsTwo main aspects with different subthemes were identified during the interviews. One main aspect focused on organizational context, such as the treatment day process, or experiences with different stakeholders, such as with the health insurance company or physicians. The other category referred to experiences that influenced psychosocial factors, including physical and mental experiences.Discussion and ConclusionPatients reported different experiences concerning physical, psychological and organizational areas during chemotherapy. Nevertheless, some potential areas for improving care, and therefore the quality of life of patients with lung cancer, could be identified. These improvement measures highlighted that with small, non‐time‐consuming and inexpensive changes, the treatment for patients with lung cancer can be improved.